Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-009920

Options or other derivatives

  • COO & Chief Financial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LOWE CHRISTOPHER P. · COO & Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-09 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X03/doc4.xml…